United States · What does Pathway Bioventures invest in?
Pathway Bioventures invests most often at Series A (100% of the rounds on record), in sectors such as Medical Devices, Gene Therapy and Drugs.
Pathway Bioventures highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A: 100% of its rounds
What they do
Pathway Bioventures invests in early-stage precision therapeutics companies addressing important unmet medical needs.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries B
- Sectors
- Medical DevicesGene TherapyDrugs
- Based in
- Chicago, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2026
1 round
- May
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
7 of 11 we have independently watched raise
AfferenceAirnaCytovaleNionyxbioOchre-bioSciotobiosciencesSimergent4biocapitalAxonisCytospireMirecule
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.